SALT LAKE CITY, April 16 /PRNewswire/ -- ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced today that company co-founder Carl R. Kjeldsberg, MD, will retire as chief executive officer (CEO) at the end of June 2009. Kjeldsberg has held the position since 1993 and will continue after his retirement to serve as chairman of the Board.
Effective, July 1, 2009, Edward R. Ashwood, MD, will assume the position of CEO of ARUP Laboratories. Ashwood, director of laboratories and chief medical officer, has been with ARUP for 22 years and has been a member of its executive management team for the last 12 years. He is a tenured professor of Pathology at the University of Utah School of Medicine and is board certified in clinical and chemical pathology.
"During my years at ARUP, the company has gone through an incredible amount of change. I have a great sense of pride in what our leadership team has accomplished under my tenure as CEO and I look forward to continuing to contribute to the future success as chairman of the Board," said Kjeldsberg.
"ARUP has positioned itself for the future by developing leaders who continue to drive the ongoing growth and success of our laboratory. Dr. Ashwood brings many years of experience and successful leadership to his new role at ARUP," continued Kjeldsberg.
"I am honored to have the opportunity to lead the company and further build on its past successes. Our priorities as a company will continue to center around our core strategic initiatives of supporting patients as well as our clients' existing test menus by offering highly complex tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services," said Ashwood. "I am very excited about the future and the opportunities that lie ahead for ARUP."
About ARUP Laboratories
|SOURCE ARUP Laboratories|
Copyright©2008 PR Newswire.
All rights reserved